A brief history of the development of Shenzhen Neptune Star Medicine Co., Ltd.

In 2002, Nepstar formed an alliance with Medicine Shoppe, the first professional pharmacy in the United States, and devoted itself to introducing the advanced professional pharmacy management technology from the United States into the pharmaceutical retail chain industry in China.

In 2003, Nepstar teamed up with Beijing Tongrentang (Group) and Beijing Capital to establish Beijing Tongrentang Commercial Investment Development Co., Ltd. to develop Tongrentang modern Chinese medicine pharmacy and make contributions to the health of Chinese medicine.

In September 2004, Goldman Sachs, the world's most famous investment bank, signed a direct investment agreement with Neptune Group, the major shareholder of Neptune Star, and Neptune Star became the first pharmaceutical retail enterprise in China to accept foreign direct investment.